Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Seok Choi, Jun-Ho Lee, Seikwan Oh, Hyewhon Rhim, Sang-Mok Lee, Seung-Yeol Nah
Index: Mol. Cells 15(1) , 108-13, (2003)
Full Text: HTML
Abstract
Treatment with ginsenosides, major active ingredients of Panax ginseng, produces a variety of pharmacological or physiological responses with effects on the central and peripheral nervous systems. Recent reports showed that ginsenoside Rg2 inhibits nicotinic acetylcholine receptor-mediated Na+ influx and channel activity. In the present study, we investigated the effect of ginsenoside Rg2 on human 5-hydroxytryptamine3A (5-HT3A) receptor channel activity, which is also one of the ligand-gated ion channel families. The 5-HT3A receptor was expressed in Xenopus oocytes, and the current was measured using the two-electrode voltage clamp technique. The ginsenoside Rg2 itself had no effect on the oocytes that were injected with H2O as well as on the oocytes that were injected with the 5-HT3A receptor cRNA. In the oocytes that were injected with the 5-HT3A receptor cRNA, the pretreatment of ginsenoside Rg2 inhibited the 5-HT-induced inward peak current (I5-HT) The inhibitory effect of ginsenoside Rg2 on I5-HT was dose dependent and reversible. The half-inhibitory concentrations (IC50) of ginsenoside Rg2 was 22.3 +/- 4.6 microM. The inhibition of I5-HT by ginsenoside Rg2 was non-competitive and voltage-independent. These results indicate that ginsenoside Rg2 might regulate the 5-HT3A receptors that are expressed in Xenopus oocytes. Further, this regulation on the ligand-gated ion channel activity by ginsenosides might be one of the pharmacological actions of Panax ginseng.
Related Compounds
Related Articles:
Microbial transformation of 20(S)-protopanaxatriol-type saponins by Absidia coerulea.
2007-07-01
[J. Nat. Prod. 70(7) , 1203-6, (2007)]
1998-01-12
[Eur. J. Pharmacol. 341(2-3) , 139-44, (1998)]
2001-10-01
[Biochem. Pharmacol. 62(7) , 943-51, (2001)]
2003-03-01
[Planta Med. 69(3) , 285-6, (2003)]
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1.
2003-04-01
[Chem. Pharm. Bull. 51(4) , 404-8, (2003)]